Current Edition

Current Features

Harnessing The Power of Solid Form and Particle Engineering to Overcome Solubility and Bioavailability Challenges

An Interview with Veranova’s Craig Grant Persistent challenges in poor solubility and low bioavailability have long impeded the pharmaceutical development pipelin...
Continue Reading →
Current Features

Navigating the 2024 Life Science Landscape:Trends, Challenges, and Opportunities

As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside an abundance of exciting opportunities. ...
Continue Reading →
Current Features

Proposed March-in Guidance Signals Funding Agencies toActively Evaluate Government Rights Under the Bayh-dole Act

The Bayh-Dole Act (“Bayh-Dole”) governs the rights to inventions made with federal assistance. It offers ownership rights to federal award recipients (“Contractors”)...
Continue Reading →
Current Features

Updating Your Regulatory Information Management Capability? It Could Pay to Get Hands-on

Letting business-savvy techies play around with a new RIM system ahead of the proposed implementation could save Life Sciences companies a fortune, says Romuald Brau...
Continue Reading →
Current Features

The Delivery of Pharmaceutical Drugs and How it Will Change the Future

Pharmaceutical drugs have seen a seismic shift over the past ten years, moving away from chemically synthesised drugs to focus more on a new class of biological drug...
Continue Reading →
Current Features

Big Data, Personalised Medicine and Support for Healthcare Professionals

What Will Drive Pharma in 2024? In 2023, precision targeting for personalised medicines, improving the information flow between reps and healthcare professionals,...
Continue Reading →
Current Features

Novel Drugs: Challenging Entrenched Prescriber/Investment Behaviour is not Just About Education

Behavioural science’s time has come in the pharma industry, as medical communications adapt to a more ambitious and diverse treatment landscape. Drawing on examples ...
Continue Reading →
Current Features

Transforming the Biologics Product Lifecycle with Inhalation Innovation

In recent years, the biopharma[1]ceuticals landscape has witnessed a revolutionary shift with the emergence of new nasal inhalation technologies. Among these, soft m...
Continue Reading →
Current Features

Why is Real World Data the Key to Rare Disease Success?

The quest to understand and treat rare diseases is among the most challenging and vital missions in healthcare today. As the industry seeks innovative solutions, Rea...
Continue Reading →
Current Features

Advancing Therapeutic Solutions with Antibody-drug Conjugates (ADCs)

As promising therapeutic agents for treating oncology indications, antibody-drug conjugates (ADCs) have become prominent in the biopharmaceutical market in recent ye...
Continue Reading →